#liver cancer

Checkpoint Immunotherapy Looks Promising for Operable Liver Cancer

Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.

Researchers compared liver-related death rates among Mexicans, Puerto Ricans and Cubans.

This good news indicates that direct-acting antiviral (DAA) treatment is safe for those who have treated their liver cancer.

Changes include approval of new drug therapies, using existing drugs more effectively and revising protocols to reduce toxic side effects.

Approach prevents cancers from making proteins they need to grow and to evade the immune system, while leaving healthy cells unharmed.

Seventy percent of liver cancer patients had either a partial response or stable disease.

Better antiretrovirals have likely mitigated HIV’s effects on the risk of end-stage liver disease and liver cancer in those with hep C.

Cabometyx is the third liver cancer drug approved in the past six months.

Those who exercise build up less liver fat, which is tied to inflammation that may give rise to cancer.

Cancer mortality declined by 27 percent over the past 25 years.

Researchers compared direct-acting-antiviral treatment outcomes between those with and without a history of liver cancer.

What’s more, such treatment is linked to remission of non–Hodgkin lymphoma.

Shawne Jabonero Lopes, DACM, LAc, shares her family’s liver health story.

Rick George credits his spiritual life with seeing him through multiple health crises, including liver cancer.